126327-47-7

Upstream product

• 107024-79-3 methyl 2-<(4-tert-butyldimethylsilyloxy)phenyl>propionate 
• 107024-78-2 dimethyl <3-<4-(tert-butyldimethylsiloxy)phenyl>-2-oxobutyl>phosphonate 
• 94903-80-7 [1S-[1α,2α(5Z)3α,4α]]-7-[3-Formyl-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methyl ester 

Downstream Products

• 107024-81-7 methyl <1S-<1α,2α(Z),3α(E,3S^*,4R^*),4α>>-7-<3-<3-hydroxy-4-<4-(tert-butyldimethylsiloxy)phenyl>-1-pentenyl>-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptenoate 
• 107080-60-4 (Z)-7-((1S,2R,3S,4R)-3-{(E)-(3R,4R)-4-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-3-hydroxy-pent-1-enyl}-7-oxa-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid methyl ester 
• 107024-77-1 <1S-<1α,2α,(Z),3α(1E,3S^*,4R^*),4α>>-7-<3-<-hydroxy-4-(4-hydroxyphenyl)-1-pentenyl>-7-oxabicyclo<2.2.1>hept-2-yl>-5-heptenoic acid 

Relevant academic research and scientific papers

9,11-Epoxy-9-homoprosta-5-enoic acid analogues as thromboxane A2 receptor antagonists

A novel bicyclic prostaglandin analogue, (1S)-[1α,2α(Z),3α(1E,3S*,4R*),4α]-7-[3-(3-hydroxy-4-phenyl-1-pen tenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (4), was found to be a potent and selective thromboxane A2 (TxA2) recepto